NT-proBNP is the most reliable biomarker for the diagnosis, prognosis and management of HF, thanks to its biological stability and non-interference with neprilysin, currently the target of sacubitril/valsartan [28, 29]. The gene discussed is NPPB; the disease is hydrops fetalis.